Stratpharma is participating and sponsoring clinical trials in many places globally.
Stratpharma ongoing clinical trials
Feel free to explore our scope of global clinical initiatives on the map below.
Product: Stratacel
United States
Trial objective: Is SC more effective than the Standard Clinical Practice in improving overall asethetic outcome and patient symptoms following facial laser treatment.
Status: Ongoing
Product: Stratacel
United States
Trial objective: “Is Stratacel® is more effective than standard of care in limiting severity and duration of treatment site reactions and patient downtime following microneedling procedure. ”
Status: Planned
Product: Stratamark
United States
Trial objective: Is the likelihood of developing stretchmarks during pregnancy lower when using SK v treatment with a placebo product
Status: Planned
Product: Stratamed
United States
Trial objective: Is the occurrance of contact dermititis reduced when using SM in wound healing v topical antibiotics creams
Status: Ongoing
Product: StrataXRT
United States
Trial objective: Is StrataXRT more effective in the treatment and prevention of radiation dermatitis than standard clinical practice
Status: Planned
Product: Stratamark
Singapore
Trial objective: Survey of stretchmark prevelance in multi ethnic population
Status: Complete
Product: Stratamark
Singapore
Trial objective: A comparison of improvement in the appearance of stretchmarks and patient comfort when using SK compared to surveyed population
Status: Data Analysis Stage
Product: StrataXRT
Singapore
Trial objective: Is the prevention of radiation dermatitis and cost effectiveness of treatment superior with StrataXRT in comparison to standard Clinical Practice
Status: Planned
Product: Strataderm
Australia
Trial objective: Is SD or SD + the standard of care more effective than standard clinical practice alone in improving burn scar outcomes and patient symptoms in children
Status: Ongoing
Product: Stratamark
Australia
Trial objective: Assessment of efficacy, safety and tolerability of SK in prevention and treatment of Stretchmarks
Status: Data Analysis Stage
Product: Stratamark
Australia
Trial objective: Is the likelihood of developing stretchmarks during pregnancy lower when using SK v prevalance data
Status: Ongoing
Product: Stratamark
Australia
Trial objective: Comparison of stretchmark development during pregnancy when using SK v treatment with a placebo product
Status: Ongoing
Product: Stratamed
Australia
Trial objective: Does Stratamed fasten wound healing in burns injuries not requiring surgery standard clinical practice
Status: Planned
Product: Stratamed/Strataderm combo
Australia
Trial objective: Does using SM & SD achieve improved sternotomy scar outcomes in comparison to standard practice following cardiac surgery in paedeatric patients
Status: Ongoing
Product: StrataXRT
Australia
Trial objective: Is the prevention and treatment of radiation dermatitis superior with the use StrataXRT vs. Standard Clinical Practice
Status: Planned
Product: StrataXRT
Australia
Trial objective: Assessment of how effective the use of StrataXRT is in comparison to Standard Clinical Practice in the prevention and management of radiation dermatitis
Status: Ongoing
Product: StrataXRT
Australia
Trial objective: Assessment of whether StrataXRT is as good as competitor treatment in reducing the severity and duration of radiation induced dermatitis
Status: Ongoing
Product: StrataXRT
Australia
Trial objective: Assessment of the effectiveness of StratXRT in the treatment of antitumoral treatment – induced skin reactions
Status: Planned
Product: StrataXRT
Australia
Trial objective: Does the application of StrataXRT on donor wound sites improve wound healing time and scar outcomes
Status: Planned
Participating in clinical trials
Are you interested in participating in one of the planned or ongoing clinical trials of Stratpharma products?
Latest clinical results and publications
A glance over the latest clinical data using Stratpharma products.
Investigator initiated trials
Are you interested in trialing Stratpharma products in your research institution or clinic?